In the BioHarmony Drug Report Database

"Preview" Icon

Ondansetron

Zofran Odt, Zuplenz (ondansetron) is a small molecule pharmaceutical. Ondansetron was first approved as Zofran Odt on 1999-01-27. It is used to treat alcoholism in the USA. Ondansetron’s patent is valid until 2030-07-13 (FDA).

 

Trade Name

 

Zofran Odt, Zuplenz
 

Common Name

 

ondansetron
 

ChEMBL ID

 

CHEMBL46
 

Indication

 

alcoholism
 

Drug Class

 

Serotonin 5-HT3 antagonists

Image (chem structure or protein)

Ondansetron structure rendering